Figure 3.

Independent association of the use of an ribavirin-free regimen (the reference regimen: sofosbuvir + ribavirin) with the end-of-treatment patient-reported outcomes (PROs) after adjustment for clinical and demographic PRO predictors. Multiple regression beta values are shown with their 95% confidence intervals. P < .05 for all PROs except for 6 PROs (SF-36: bodily pain, general health, physical component summary; FACIT-F: emotional well-being, social well-being; CLDQ-HCV: worry). Abbreviations: CLDQ-HCV, chronic liver disease questionnaire-hepatitis C virus version; FACIT-F, functional assessment of chronic illness therapy-fatigue; PRO, patient-reported outcome; SF-36, short-form-36; WPAI:SHP, work productivity activity index:specific health problem.